Mass drug administration approved and candidate anthelmintics beginning on larval stage 1 Caenorhabditis elegans are generally potent, suggesting a novel, pre-infective control for helminths - Sam A. Attalla; Kathryn J. Isaac; Morgan Pfeffer; Justin R. Hockaday; Raegan Weatherly; Malia B. Asselin; Allison K. Lewis; Viveke Rai; William A. Huff Jr; Mason H. Long; Tashna Placide; Kala R. Pearce; et al. (PLoS ONE, 2026)